Search research articles
Contact Us
Filters
Showing results (781-790 of 1,115) with videos related to
Page
of 112
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response
V Gandhi, W Plunkett, C O Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells
V Gandhi, W Plunkett, S Weller, et al.
Blood
|
May 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor
E H Estey, D Dixon, H M Kantarjian, et al.
Cancer
|
August 23, 2011
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia
Bang-Ning Lee, Hui Gao, Evan N Cohen, et al.
Leukemia
|
February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
J Hoellenriegel, G P Coffey, U Sinha, et al.
Blood
|
January 20, 2011
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Xavier C Badoux, Michael J Keating, Xuemei Wang, et al.
Stem Cells (Dayton, Ohio)
|
August 9, 2008
Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro
Robert A Rose, Huijie Jiang, Xinghua Wang, et al.
Cancer
|
August 12, 2003
Phase II study of alemtuzumab in chronic lymphoproliferative disorders
Alessandra Ferrajoli, Susan M O'Brien, Jorge E Cortes, et al.
Leukemia & Lymphoma
|
February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia
Uri Rozovski, David M Harris, Ping Li, et al.
Blood
|
June 25, 2008
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
Dunyaporn Trachootham, Hui Zhang, Wan Zhang, et al.
Page
of 112
Search research articles
Search
Showing results (781-790 of 1,115) with videos related to
Sort By:
Page
of 112
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 17, 1998
Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response
V Gandhi, W Plunkett, C O Rodriguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 17, 2001
Evaluation of the combination of nelarabine and fludarabine in leukemias: clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells
V Gandhi, W Plunkett, S Weller, et al.
Blood
|
May 1, 1990
Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor
E H Estey, D Dixon, H M Kantarjian, et al.
Cancer
|
August 23, 2011
Treatment with lenalidomide modulates T-cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia
Bang-Ning Lee, Hui Gao, Evan N Cohen, et al.
Leukemia
|
February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
J Hoellenriegel, G P Coffey, U Sinha, et al.
Blood
|
January 20, 2011
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Xavier C Badoux, Michael J Keating, Xuemei Wang, et al.
Stem Cells (Dayton, Ohio)
|
August 9, 2008
Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro
Robert A Rose, Huijie Jiang, Xinghua Wang, et al.
Cancer
|
August 12, 2003
Phase II study of alemtuzumab in chronic lymphoproliferative disorders
Alessandra Ferrajoli, Susan M O'Brien, Jorge E Cortes, et al.
Leukemia & Lymphoma
|
February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemia
Uri Rozovski, David M Harris, Ping Li, et al.
Blood
|
June 25, 2008
Effective elimination of fludarabine-resistant CLL cells by PEITC through a redox-mediated mechanism
Dunyaporn Trachootham, Hui Zhang, Wan Zhang, et al.
Page
of 112